2017-03-16,Karyopharm Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Selinexor Clinical Update
2017-03-10,Karyopharm Announces Partial Clinical Hold To Pause Enrollment In Selinexor Trials
2017-03-09,Karyopharm To Report Fourth Quarter And Year End 2016 Financial Results On March 16, 2017
2017-03-03,Biotech Premarket Movers: Karyopharm, Lexicon, Prothena
2017-03-02,Karyopharm Announces Results From Interim Analysis Of Phase 2 SOPRA Study Evaluating Selinexor In Relapsed/Refractory Acute Myeloid Leukemia
2017-03-01,Karyopharm Announces The Presentation Of New Data At The 2017 American Association For Cancer Research Annual Meeting
2017-01-31,Karyopharm To Participate In Upcoming Investor Conferences
2017-01-19,Commit To Buy Karyopharm Therapeutics At $7.50, Earn 19.6% Annualized Using Options
2017-01-12,Short Interest Jumps 19.7% For KPTI
2017-01-03,Karyopharm To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016-12-15,Karyopharm And Collaborators Awarded Grant For ALS Research
2016-12-05,Karyopharm Presents Updated Phase 1b STOMP Data At The American Society Of Hematology 2016 Annual Meeting
2016-12-04,Karyopharm Presents Updated Phase 2b STORM Data At The American Society Of Hematology 2016 Annual Meeting
2016-12-04,Karyopharm Presents Updated Phase 2 SAIL Relapsed/Refractory AML Clinical Data At The American Society Of Hematology 2016 Annual Meeting
2016-11-30,Karyopharm And The Multiple Myeloma Research Foundation Announce Panel Discussion Featuring Leading Multiple Myeloma Thought Leaders
2016-11-10,Karyopharm To Present At The Jefferies 2016 London Healthcare Conference
2016-11-07,Karyopharm Reports Third Quarter 2016 Financial Results And Highlights Recent Progress
2016-11-03,Karyopharm To Present Updated Phase 2b STORM And Phase 1b STOMP Clinical Data At The American Society Of Hematology 2016 Annual Meeting
2016-11-02,Karyopharm To Ring The Nasdaq Stock Market Closing Bell
2016-10-31,Karyopharm To Report Third Quarter 2016 Financial Results On November 7, 2016
2016-10-28,Karyopharm Therapeutics is Now Oversold (KPTI)
2016-10-20,Commit To Purchase Karyopharm Therapeutics At $7.50, Earn 32.4% Annualized Using Options
2016-10-11,Karyopharm To Present At The 15th Annual BIO Investor Forum
2016-10-05,Karyopharm To Present Updated SIGN Phase 2 Clinical Data At European Society Of Medical Oncology 2016 Annual Meeting
2016-09-29,Karyopharm Publishes Preclinical Data In Nature Demonstrating Selinexor's Potential In KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
2016-09-28,Karyopharm Publishes Preclinical And Phase 1 Clinical Data For Selinexor In Ovarian Cancer In Clinical Cancer Research Publication
2016-09-12,Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP As Senior Vice President, Clinical Development
2016-09-06,Karyopharm Sees Quicker U.S. Approval Path for Multiple Myeloma Drug
2016-09-06,Karyopharm Reports Positive Top-Line Phase 2b STORM Results And Reviews The Planned Development Path For Selinexor In Multiple Myeloma
2016-08-30,Markets Very Sluggish as August Nears an End
2016-08-30,Karyopharm To Host Conference Call With Update On Multiple Myeloma Plans
2016-08-22,Noteworthy Monday Option Activity: KPTI, SHLD, MXWL
2016-08-19,These 7 Stocks Under $10 Could Make You a Lot of Money
2016-08-04,Karyopharm Reports Second Quarter 2016 Financial Results And Highlights Recent Progress
2016-08-03,Karyopharm To Present At Upcoming Investor Conferences
2016-07-28,Karyopharm To Report Second Quarter 2016 Financial Results On August 4, 2016
2016-07-27,Karyopharm To Present Updated Phase 2 Clinical Data From SIGN Study At European Society Of Medical Oncology 2016 Annual Meeting
2016-07-27,Karyopharm Announces Phase 1b Selinexor Sarcoma Data Published In Journal Of Clinical Oncology
2016-07-19,Commit To Purchase Karyopharm Therapeutics At $5, Earn 20.6% Annualized Using Options
2016-07-06,Karyopharm To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-06-22,Karyopharm Initiates Phase 1 Clinical Trial With KPT-9274
2016-06-16,Oversold Conditions For Karyopharm Therapeutics (KPTI)
2016-06-16,Karyopharm Outlines Key Selinexor Clinical Development Achievements
2016-06-15,Karyopharm To Present At The 2016 JMP Securities Life Science Conference
2016-06-10,Karyopharm Presents Preliminary STOMP Phase 1b Clinical Data At 2016 European Hematology Association Annual Meeting
2016-06-07,Insider Trading Alert - TRUP, KPTI And FCBC Traded By Insiders
2016-06-01,Karyopharm To Present At The Jefferies 2016 Healthcare Conference
2016-05-31,Insider Trading Alert - KPTI, CPIX And LB Traded By Insiders
2016-05-24,Insider Trading Alert - W, KPTI And GVP Traded By Insiders
2016-05-19,Karyopharm To Present Preliminary STOMP Phase 1B Clinical Data At 2016 European Hematology Association Annual Meeting
2016-05-18,Karyopharm To Present Selinexor Clinical Data At The American Society Of Clinical Oncology Annual Meeting
2016-05-09,Karyopharm Reports First Quarter 2016 Financial Results And Highlights Recent Progress
2016-05-02,Karyopharm To Report First Quarter 2016 Financial Results On May 9, 2016
2016-04-20,Karyopharm Presents Data Demonstrating The Potential Of Nuclear Export Protein Exportin 1 (XPO1) Inhibition In The Treatment Of Traumatic Brain Injury
2016-04-06,Karyopharm Taps TransPerfect As ETMF And Functional TMF Provider
2016-04-05,Karyopharm To Present At The 15th Annual Needham Healthcare Conference
2016-03-31,Karyopharm Receives NIAID Grant To Advance Development Of KPT-350 For The Treatment Of Lupus
2016-03-22,Karyopharm Therapeutics (KPTI) Strong On High Relative Volume Today
2016-03-16,Karyopharm To Present Data On Oncology Pipeline At The 2016 American Association For Cancer Research Annual Meeting
2016-03-14,Karyopharm Reports Fourth Quarter And Full Year 2015 Financial Results And Highlights Recent Progress
2016-03-07,Karyopharm To Report Fourth Quarter And Full Year 2015 Financial Results On March 14, 2016
2016-03-04,Karyopharm's Selinexor First-in-Human Phase 1 Clinical Trial Data Published In Journal Of Clinical Oncology
2016-03-02,7 Stocks Under $10 Making Big Breakout Moves
2016-02-03,Karyopharm To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-01-21,5 Stocks Under $10 Set to Soar
2016-01-19,Karyopharm Initiates Second Generation SINE™ Compound Clinical Trial In Multiple Myeloma
2016-01-14,Karyopharm Initiates Clinical Trial Of Oral Selinexor In Advanced Liposarcoma
2016-01-06,Karyopharm Therapeutics is Now Oversold (KPTI)
2016-01-06,Karyopharm Therapeutics (KPTI) Highlighted As Weak On High Volume
2016-01-04,Karyopharm To Present At The 34th Annual J.P. Morgan Healthcare Conference
2015-12-07,Karyopharm Therapeutics Presents Positive Clinical Data On The Activity Of Selinexor In Combination With Other Anticancer Agents Across Multiple Hematologic Malignancies At The 2015 American Society Of Hematology (ASH) Annual Meeting
2015-11-30,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Hematologic Malignancies
2015-11-13,Karyopharm Therapeutics Stock Sees Short Interest Drop 13.5%
2015-11-09,Karyopharm Reports Third Quarter 2015 Financial Results And Highlights Recent Progress
2015-11-05,Karyopharm To Present Data On Oncology Pipeline At American Society Of Hematology 2015 Annual Meeting
2015-11-02,Karyopharm To Report Third Quarter 2015 Financial Results On November 9, 2015
2015-10-30,5 Stocks Ready to Break Out Higher
2015-10-19,Karyopharm Initiates STOMP Clinical Trial Of Oral Selinexor In Multiple Myeloma
2015-10-13,Short Interest Falls 11% For KPTI
2015-09-30,10 Worst NASDAQ Biotech Stocks in the Third Quarter
2015-09-29,Karyopharm Therapeutics is Now Oversold (KPTI)
2015-09-03,Karyopharm Advancing Neuroprotective SINE(TM) Compounds In Amyotrophic Lateral Sclerosis (ALS)
2015-08-28,5 Breakout Stocks to Trade for Big Gains
2015-08-25,Strong On High Relative Volume: Karyopharm Therapeutics (KPTI)
2015-08-18,Karyopharm Therapeutics is Now Oversold (KPTI)
2015-08-18,Perilous Reversal Watch: Karyopharm Therapeutics (KPTI)
2015-08-17,Karyopharm Therapeutics (KPTI) Showing Signs Of A Dead Cat Bounce Today
2015-08-14,Weak On High Volume: Karyopharm Therapeutics (KPTI)
2015-08-11,Karyopharm Therapeutics (KPTI) Is Strong On High Volume Today
2015-08-10,Karyopharm Reports Second Quarter 2015 Financial Results And Highlights Recent Progress
2015-08-06,Commit To Purchase Karyopharm Therapeutics At $20, Earn 31% Annualized Using Options
2015-08-04,Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China
2015-08-03,Karyopharm To Report Second Quarter 2015 Financial Results On August 10, 2015
2015-07-24,Oversold Conditions For Karyopharm Therapeutics (KPTI)
2015-07-07,KPTI: Insiders Vs. Shorts
2015-06-26,Short Interest Increases 11.6% For KPTI
2015-06-22,Karyopharm Presents Hematologic Cancer Data On Lead Drug Candidate Selinexor At International Conference On Malignant Lymphoma
2015-06-15,Karyopharm Presents Hematologic Cancer Data On Lead Drug Candidate Selinexor At European Hematology Association Annual Meeting
2015-06-05,5 Biotech Stocks Poised for Breakouts
2015-06-04,'Mad Money' Lightning Round: Buy, Buy, Buy Juno Therapeutics
2015-06-03,Jim Cramer's 'Mad Money' Recap: Individual Stocks Beat Baskets Any Day
2015-06-01,Karyopharm Presents Clinical Data For Selinexor (KPT-330) In Patients With Recurrent Glioblastoma And Advanced Sarcomas At 2015 ASCO Annual Meeting
2015-05-30,Karyopharm Presents Clinical Data For Selinexor (KPT-330) In Patients With Heavily Pretreated Gynecological Cancers And Asian Patients With Advanced Malignancies At 2015 ASCO Annual Meeting
2015-05-29,Fly Watch: Several Names That May Move Following ASCO Meeting
2015-05-28,Karyopharm Initiates STORM Clinical Trial Of Oral Selinexor (KPT-330) In Multiple Myeloma
2015-05-27,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Solid Tumors
2015-05-21,Karyopharm To Present Hematologic Cancer Data On Lead Drug Candidate Selinexor At European Hematology Association Annual Meeting
2015-05-14,Karyopharm Therapeutics (KPTI) Stock: Weak On High Volume Today
2015-05-13,Karyopharm To Present Solid Tumor Data On Lead Drug Candidate Selinexor At 2015 American Society Of Clinical Oncology Annual Meeting
2015-05-13,Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts
2015-05-11,Karyopharm Reports First Quarter 2015 Financial Results And Highlights Recent Progress
2015-05-07,Karyopharm To Present At Bank Of America Merrill Lynch 2015 Healthcare Conference
2015-05-06,Commit To Purchase Karyopharm Therapeutics At $20, Earn 12.9% Annualized Using Options
2015-05-05,Karyopharm To Report First Quarter 2015 Financial Results On May 11, 2015
2015-04-17,Karyopharm To Present Late-Breaking Data At American Association For Cancer Research Annual Meeting
2015-04-14,Ratings Changes Today
2015-04-13,Karyopharm Granted U.S. Composition-of-Matter Patent For Selinexor (KPT-330)
2015-04-07,KPTI: Insiders Vs. Shorts
2015-04-02,'Mad Money' Lightning Round: Kinder Morgan, HCA Are Winners
2015-04-01,Jim Cramer's 'Mad Money' Recap: Get Ready for a Rough Ride
2015-04-01,Karyopharm Appoints Mikael Dolsten, MD, PhD To Its Board Of Directors
2015-03-18,Karyopharm To Present Data On Its Novel Oral PAK4 Allosteric Modulator (PAM) At The American Association For Cancer Research Annual Meeting
2015-03-18,Karyopharm To Present Data On Oncology Pipeline At American Association For Cancer Research Annual Meeting
2015-03-16,Karyopharm Reports Fourth Quarter And Full Year 2014 Financial Results And Highlights Recent Progress
2015-03-09,Karyopharm To Report Fourth Quarter And Full Year 2014 Financial Results On March 16, 2015
2015-02-23,Nature Neuroscience Publishes Data Demonstrating Potential Therapeutic Benefits Of Karyopharm's SINE(TM) Compounds In The Treatment Of Multiple Sclerosis
2015-02-05,Karyopharm To Present At Leerink Partners Global Healthcare Conference
2015-01-26,Commit To Purchase Karyopharm Therapeutics At $22.50, Earn 19.6% Annualized Using Options
2015-01-16,Karyopharm Therapeutics Is Now Oversold (KPTI)
2015-01-08,Karyopharm Announces Orphan Designation Granted By FDA For Selinexor (KPT-330) In Multiple Myeloma
2015-01-07,Karyopharm To Present At J.P. Morgan 33rd Annual Healthcare Conference
2015-01-06,Karyopharm Therapeutics Announces Pricing Of Public Offering Of Common Stock
2015-01-05,Karyopharm Therapeutics Announces Proposed Public Offering Of Common Stock
2014-12-15,Karyopharm Announces Addition To The NASDAQ Biotechnology Index
2014-12-11,Karyopharm Initiates Third Registration-Directed Clinical Trial Of Oral Selinexor (KPT-330)
2014-12-08,Jim Cramer's 'Mad Money' Recap: Why You Should Buy Disney, Starbucks, Nike Now
2014-12-08,Karyopharm Presents Positive Clinical Data For Selinexor (KPT-330) In NHL Patients At ASH 2014 Annual Meeting
2014-12-08,Karyopharm Presents Positive Combination Data For Selinexor (KPT-330) In Multiple Myeloma Patients At ASH 2014 Annual Meeting
2014-12-04,Karyopharm To Present At Oppenheimer 25th Annual Healthcare Conference
2014-12-01,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Oncology
2014-12-01,Karyopharm Announces Additional Orphan Designations Granted For Selinexor (KPT-330) By European Commission
2014-11-24,Karyopharm Presents Data On Oncology Pipeline At EORTC-NCI-AACR Annual Meeting
2014-11-10,Karyopharm Reports Third Quarter 2014 Financial Results And Highlights Recent Progress
2014-11-10,Karyopharm Initiates Registration-Directed Clinical Study Of Selinexor (KPT-330) In Patients With Richter's Transformation
2014-11-06,Karyopharm Announces Data Presentations At American Society Of Hematology Annual Meeting
2014-11-05,Karyopharm To Present At Credit Suisse 2014 Healthcare Conference
2014-11-04,Karyopharm Appoints J. Scott Garland To Its Board Of Directors
2014-10-30,Karyopharm To Report Third Quarter 2014 Financial Results On November 10, 2014
2014-10-27,Karyopharm Expands Global Presence With European Subsidiary
2014-09-29,Karyopharm Announces Clinical Data For Selinexor (KPT-330) In Advanced Solid Tumors
2014-09-29,3 Unusual-Volume Biotech Stocks in Breakout Territory
2014-09-25,Karyopharm To Host Conference Call To Discuss Selinexor (KPT-330) Data Presented At ESMO 2014
2014-09-09,Karyopharm Announces Three Clinical Data Presentations At ESMO 2014
2014-08-08,Karyopharm Appoints Justin Renz Executive Vice President And Chief Financial Officer
2014-08-07,Karyopharm To Present At The Wedbush 2014 Life Sciences Management Access Conference
2014-08-07,Karyopharm Therapeutics Reports Second Quarter Financial Results For 2014
2014-08-01,Karyopharm To Host Second Quarter 2014 Earnings Call On August 7, 2014
2014-06-17,A Beaten-Down Biotech Stock Poised for an Epic Short Squeeze
2014-06-03,3 Big-Volume Stocks in Breakout Territory
2014-05-30,ASCO '14: What's on Tap for Saturday
2014-05-28,5 Stocks Insiders Love Right Now
2017-03-16,Karyopharm Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Selinexor Clinical Update
2017-03-10,Karyopharm Announces Partial Clinical Hold To Pause Enrollment In Selinexor Trials
2017-03-09,Karyopharm To Report Fourth Quarter And Year End 2016 Financial Results On March 16, 2017
2017-03-03,Biotech Premarket Movers: Karyopharm, Lexicon, Prothena
2017-03-02,Karyopharm Announces Results From Interim Analysis Of Phase 2 SOPRA Study Evaluating Selinexor In Relapsed/Refractory Acute Myeloid Leukemia
2017-03-01,Karyopharm Announces The Presentation Of New Data At The 2017 American Association For Cancer Research Annual Meeting
2017-01-31,Karyopharm To Participate In Upcoming Investor Conferences
2017-01-19,Commit To Buy Karyopharm Therapeutics At $7.50, Earn 19.6% Annualized Using Options
2017-01-12,Short Interest Jumps 19.7% For KPTI
2017-01-03,Karyopharm To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016-12-15,Karyopharm And Collaborators Awarded Grant For ALS Research
2016-12-05,Karyopharm Presents Updated Phase 1b STOMP Data At The American Society Of Hematology 2016 Annual Meeting
2016-12-04,Karyopharm Presents Updated Phase 2b STORM Data At The American Society Of Hematology 2016 Annual Meeting
2016-12-04,Karyopharm Presents Updated Phase 2 SAIL Relapsed/Refractory AML Clinical Data At The American Society Of Hematology 2016 Annual Meeting
2016-11-30,Karyopharm And The Multiple Myeloma Research Foundation Announce Panel Discussion Featuring Leading Multiple Myeloma Thought Leaders
2016-11-10,Karyopharm To Present At The Jefferies 2016 London Healthcare Conference
2016-11-07,Karyopharm Reports Third Quarter 2016 Financial Results And Highlights Recent Progress
2016-11-03,Karyopharm To Present Updated Phase 2b STORM And Phase 1b STOMP Clinical Data At The American Society Of Hematology 2016 Annual Meeting
2016-11-02,Karyopharm To Ring The Nasdaq Stock Market Closing Bell
2016-10-31,Karyopharm To Report Third Quarter 2016 Financial Results On November 7, 2016
2016-10-28,Karyopharm Therapeutics is Now Oversold (KPTI)
2016-10-20,Commit To Purchase Karyopharm Therapeutics At $7.50, Earn 32.4% Annualized Using Options
2016-10-11,Karyopharm To Present At The 15th Annual BIO Investor Forum
2016-10-05,Karyopharm To Present Updated SIGN Phase 2 Clinical Data At European Society Of Medical Oncology 2016 Annual Meeting
2016-09-29,Karyopharm Publishes Preclinical Data In Nature Demonstrating Selinexor's Potential In KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
2016-09-28,Karyopharm Publishes Preclinical And Phase 1 Clinical Data For Selinexor In Ovarian Cancer In Clinical Cancer Research Publication
2016-09-12,Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP As Senior Vice President, Clinical Development
2016-09-06,Karyopharm Sees Quicker U.S. Approval Path for Multiple Myeloma Drug
2016-09-06,Karyopharm Reports Positive Top-Line Phase 2b STORM Results And Reviews The Planned Development Path For Selinexor In Multiple Myeloma
2016-08-30,Markets Very Sluggish as August Nears an End
2016-08-30,Karyopharm To Host Conference Call With Update On Multiple Myeloma Plans
2016-08-22,Noteworthy Monday Option Activity: KPTI, SHLD, MXWL
2016-08-19,These 7 Stocks Under $10 Could Make You a Lot of Money
2016-08-04,Karyopharm Reports Second Quarter 2016 Financial Results And Highlights Recent Progress
2016-08-03,Karyopharm To Present At Upcoming Investor Conferences
2016-07-28,Karyopharm To Report Second Quarter 2016 Financial Results On August 4, 2016
2016-07-27,Karyopharm To Present Updated Phase 2 Clinical Data From SIGN Study At European Society Of Medical Oncology 2016 Annual Meeting
2016-07-27,Karyopharm Announces Phase 1b Selinexor Sarcoma Data Published In Journal Of Clinical Oncology
2016-07-19,Commit To Purchase Karyopharm Therapeutics At $5, Earn 20.6% Annualized Using Options
2016-07-06,Karyopharm To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-06-22,Karyopharm Initiates Phase 1 Clinical Trial With KPT-9274
2016-06-16,Oversold Conditions For Karyopharm Therapeutics (KPTI)
2016-06-16,Karyopharm Outlines Key Selinexor Clinical Development Achievements
2016-06-15,Karyopharm To Present At The 2016 JMP Securities Life Science Conference
2016-06-10,Karyopharm Presents Preliminary STOMP Phase 1b Clinical Data At 2016 European Hematology Association Annual Meeting
2016-06-07,Insider Trading Alert - TRUP, KPTI And FCBC Traded By Insiders
2016-06-01,Karyopharm To Present At The Jefferies 2016 Healthcare Conference
2016-05-31,Insider Trading Alert - KPTI, CPIX And LB Traded By Insiders
2016-05-24,Insider Trading Alert - W, KPTI And GVP Traded By Insiders
2016-05-19,Karyopharm To Present Preliminary STOMP Phase 1B Clinical Data At 2016 European Hematology Association Annual Meeting
2016-05-18,Karyopharm To Present Selinexor Clinical Data At The American Society Of Clinical Oncology Annual Meeting
2016-05-09,Karyopharm Reports First Quarter 2016 Financial Results And Highlights Recent Progress
2016-05-02,Karyopharm To Report First Quarter 2016 Financial Results On May 9, 2016
2016-04-20,Karyopharm Presents Data Demonstrating The Potential Of Nuclear Export Protein Exportin 1 (XPO1) Inhibition In The Treatment Of Traumatic Brain Injury
2016-04-06,Karyopharm Taps TransPerfect As ETMF And Functional TMF Provider
2016-04-05,Karyopharm To Present At The 15th Annual Needham Healthcare Conference
2016-03-31,Karyopharm Receives NIAID Grant To Advance Development Of KPT-350 For The Treatment Of Lupus
2016-03-22,Karyopharm Therapeutics (KPTI) Strong On High Relative Volume Today
2016-03-16,Karyopharm To Present Data On Oncology Pipeline At The 2016 American Association For Cancer Research Annual Meeting
2016-03-14,Karyopharm Reports Fourth Quarter And Full Year 2015 Financial Results And Highlights Recent Progress
2016-03-07,Karyopharm To Report Fourth Quarter And Full Year 2015 Financial Results On March 14, 2016
2016-03-04,Karyopharm's Selinexor First-in-Human Phase 1 Clinical Trial Data Published In Journal Of Clinical Oncology
2016-03-02,7 Stocks Under $10 Making Big Breakout Moves
2016-02-03,Karyopharm To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-01-21,5 Stocks Under $10 Set to Soar
2016-01-19,Karyopharm Initiates Second Generation SINE™ Compound Clinical Trial In Multiple Myeloma
2016-01-14,Karyopharm Initiates Clinical Trial Of Oral Selinexor In Advanced Liposarcoma
2016-01-06,Karyopharm Therapeutics is Now Oversold (KPTI)
2016-01-06,Karyopharm Therapeutics (KPTI) Highlighted As Weak On High Volume
2016-01-04,Karyopharm To Present At The 34th Annual J.P. Morgan Healthcare Conference
2015-12-07,Karyopharm Therapeutics Presents Positive Clinical Data On The Activity Of Selinexor In Combination With Other Anticancer Agents Across Multiple Hematologic Malignancies At The 2015 American Society Of Hematology (ASH) Annual Meeting
2015-11-30,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Hematologic Malignancies
2015-11-13,Karyopharm Therapeutics Stock Sees Short Interest Drop 13.5%
2015-11-09,Karyopharm Reports Third Quarter 2015 Financial Results And Highlights Recent Progress
2015-11-05,Karyopharm To Present Data On Oncology Pipeline At American Society Of Hematology 2015 Annual Meeting
2015-11-02,Karyopharm To Report Third Quarter 2015 Financial Results On November 9, 2015
2015-10-30,5 Stocks Ready to Break Out Higher
2015-10-19,Karyopharm Initiates STOMP Clinical Trial Of Oral Selinexor In Multiple Myeloma
2015-10-13,Short Interest Falls 11% For KPTI
2015-09-30,10 Worst NASDAQ Biotech Stocks in the Third Quarter
2015-09-29,Karyopharm Therapeutics is Now Oversold (KPTI)
2015-09-03,Karyopharm Advancing Neuroprotective SINE(TM) Compounds In Amyotrophic Lateral Sclerosis (ALS)
2015-08-28,5 Breakout Stocks to Trade for Big Gains
2015-08-25,Strong On High Relative Volume: Karyopharm Therapeutics (KPTI)
2015-08-18,Karyopharm Therapeutics is Now Oversold (KPTI)
2015-08-18,Perilous Reversal Watch: Karyopharm Therapeutics (KPTI)
2015-08-17,Karyopharm Therapeutics (KPTI) Showing Signs Of A Dead Cat Bounce Today
2015-08-14,Weak On High Volume: Karyopharm Therapeutics (KPTI)
2015-08-11,Karyopharm Therapeutics (KPTI) Is Strong On High Volume Today
2015-08-10,Karyopharm Reports Second Quarter 2015 Financial Results And Highlights Recent Progress
2015-08-06,Commit To Purchase Karyopharm Therapeutics At $20, Earn 31% Annualized Using Options
2015-08-04,Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China
2015-08-03,Karyopharm To Report Second Quarter 2015 Financial Results On August 10, 2015
2015-07-24,Oversold Conditions For Karyopharm Therapeutics (KPTI)
2015-07-07,KPTI: Insiders Vs. Shorts
2015-06-26,Short Interest Increases 11.6% For KPTI
2015-06-22,Karyopharm Presents Hematologic Cancer Data On Lead Drug Candidate Selinexor At International Conference On Malignant Lymphoma
2015-06-15,Karyopharm Presents Hematologic Cancer Data On Lead Drug Candidate Selinexor At European Hematology Association Annual Meeting
2015-06-05,5 Biotech Stocks Poised for Breakouts
2015-06-04,'Mad Money' Lightning Round: Buy, Buy, Buy Juno Therapeutics
2015-06-03,Jim Cramer's 'Mad Money' Recap: Individual Stocks Beat Baskets Any Day
2015-06-01,Karyopharm Presents Clinical Data For Selinexor (KPT-330) In Patients With Recurrent Glioblastoma And Advanced Sarcomas At 2015 ASCO Annual Meeting
2015-05-30,Karyopharm Presents Clinical Data For Selinexor (KPT-330) In Patients With Heavily Pretreated Gynecological Cancers And Asian Patients With Advanced Malignancies At 2015 ASCO Annual Meeting
2015-05-29,Fly Watch: Several Names That May Move Following ASCO Meeting
2015-05-28,Karyopharm Initiates STORM Clinical Trial Of Oral Selinexor (KPT-330) In Multiple Myeloma
2015-05-27,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Solid Tumors
2015-05-21,Karyopharm To Present Hematologic Cancer Data On Lead Drug Candidate Selinexor At European Hematology Association Annual Meeting
2015-05-14,Karyopharm Therapeutics (KPTI) Stock: Weak On High Volume Today
2015-05-13,Karyopharm To Present Solid Tumor Data On Lead Drug Candidate Selinexor At 2015 American Society Of Clinical Oncology Annual Meeting
2015-05-13,Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts
2015-05-11,Karyopharm Reports First Quarter 2015 Financial Results And Highlights Recent Progress
2015-05-07,Karyopharm To Present At Bank Of America Merrill Lynch 2015 Healthcare Conference
2015-05-06,Commit To Purchase Karyopharm Therapeutics At $20, Earn 12.9% Annualized Using Options
2015-05-05,Karyopharm To Report First Quarter 2015 Financial Results On May 11, 2015
2015-04-17,Karyopharm To Present Late-Breaking Data At American Association For Cancer Research Annual Meeting
2015-04-14,Ratings Changes Today
2015-04-13,Karyopharm Granted U.S. Composition-of-Matter Patent For Selinexor (KPT-330)
2015-04-07,KPTI: Insiders Vs. Shorts
2015-04-02,'Mad Money' Lightning Round: Kinder Morgan, HCA Are Winners
2015-04-01,Jim Cramer's 'Mad Money' Recap: Get Ready for a Rough Ride
2015-04-01,Karyopharm Appoints Mikael Dolsten, MD, PhD To Its Board Of Directors
2015-03-18,Karyopharm To Present Data On Its Novel Oral PAK4 Allosteric Modulator (PAM) At The American Association For Cancer Research Annual Meeting
2015-03-18,Karyopharm To Present Data On Oncology Pipeline At American Association For Cancer Research Annual Meeting
2015-03-16,Karyopharm Reports Fourth Quarter And Full Year 2014 Financial Results And Highlights Recent Progress
2015-03-09,Karyopharm To Report Fourth Quarter And Full Year 2014 Financial Results On March 16, 2015
2015-02-23,Nature Neuroscience Publishes Data Demonstrating Potential Therapeutic Benefits Of Karyopharm's SINE(TM) Compounds In The Treatment Of Multiple Sclerosis
2015-02-05,Karyopharm To Present At Leerink Partners Global Healthcare Conference
2015-01-26,Commit To Purchase Karyopharm Therapeutics At $22.50, Earn 19.6% Annualized Using Options
2015-01-16,Karyopharm Therapeutics Is Now Oversold (KPTI)
2015-01-08,Karyopharm Announces Orphan Designation Granted By FDA For Selinexor (KPT-330) In Multiple Myeloma
2015-01-07,Karyopharm To Present At J.P. Morgan 33rd Annual Healthcare Conference
2015-01-06,Karyopharm Therapeutics Announces Pricing Of Public Offering Of Common Stock
2015-01-05,Karyopharm Therapeutics Announces Proposed Public Offering Of Common Stock
2014-12-15,Karyopharm Announces Addition To The NASDAQ Biotechnology Index
2014-12-11,Karyopharm Initiates Third Registration-Directed Clinical Trial Of Oral Selinexor (KPT-330)
2014-12-08,Jim Cramer's 'Mad Money' Recap: Why You Should Buy Disney, Starbucks, Nike Now
2014-12-08,Karyopharm Presents Positive Clinical Data For Selinexor (KPT-330) In NHL Patients At ASH 2014 Annual Meeting
2014-12-08,Karyopharm Presents Positive Combination Data For Selinexor (KPT-330) In Multiple Myeloma Patients At ASH 2014 Annual Meeting
2014-12-04,Karyopharm To Present At Oppenheimer 25th Annual Healthcare Conference
2014-12-01,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Oncology
2014-12-01,Karyopharm Announces Additional Orphan Designations Granted For Selinexor (KPT-330) By European Commission
2014-11-24,Karyopharm Presents Data On Oncology Pipeline At EORTC-NCI-AACR Annual Meeting
2014-11-10,Karyopharm Reports Third Quarter 2014 Financial Results And Highlights Recent Progress
2014-11-10,Karyopharm Initiates Registration-Directed Clinical Study Of Selinexor (KPT-330) In Patients With Richter's Transformation
2014-11-06,Karyopharm Announces Data Presentations At American Society Of Hematology Annual Meeting
2014-11-05,Karyopharm To Present At Credit Suisse 2014 Healthcare Conference
2014-11-04,Karyopharm Appoints J. Scott Garland To Its Board Of Directors
2014-10-30,Karyopharm To Report Third Quarter 2014 Financial Results On November 10, 2014
2014-10-27,Karyopharm Expands Global Presence With European Subsidiary
2014-09-29,Karyopharm Announces Clinical Data For Selinexor (KPT-330) In Advanced Solid Tumors
2014-09-29,3 Unusual-Volume Biotech Stocks in Breakout Territory
2014-09-25,Karyopharm To Host Conference Call To Discuss Selinexor (KPT-330) Data Presented At ESMO 2014
2014-09-09,Karyopharm Announces Three Clinical Data Presentations At ESMO 2014
2014-08-08,Karyopharm Appoints Justin Renz Executive Vice President And Chief Financial Officer
2014-08-07,Karyopharm To Present At The Wedbush 2014 Life Sciences Management Access Conference
2014-08-07,Karyopharm Therapeutics Reports Second Quarter Financial Results For 2014
2014-08-01,Karyopharm To Host Second Quarter 2014 Earnings Call On August 7, 2014
2014-06-17,A Beaten-Down Biotech Stock Poised for an Epic Short Squeeze
2014-06-03,3 Big-Volume Stocks in Breakout Territory
2014-05-30,ASCO '14: What's on Tap for Saturday
2014-05-28,5 Stocks Insiders Love Right Now
2017-03-16,Karyopharm Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Selinexor Clinical Update
2017-03-10,Karyopharm Announces Partial Clinical Hold To Pause Enrollment In Selinexor Trials
2017-03-09,Karyopharm To Report Fourth Quarter And Year End 2016 Financial Results On March 16, 2017
2017-03-03,Biotech Premarket Movers: Karyopharm, Lexicon, Prothena
2017-03-02,Karyopharm Announces Results From Interim Analysis Of Phase 2 SOPRA Study Evaluating Selinexor In Relapsed/Refractory Acute Myeloid Leukemia
2017-03-01,Karyopharm Announces The Presentation Of New Data At The 2017 American Association For Cancer Research Annual Meeting
2017-01-31,Karyopharm To Participate In Upcoming Investor Conferences
2017-01-19,Commit To Buy Karyopharm Therapeutics At $7.50, Earn 19.6% Annualized Using Options
2017-01-12,Short Interest Jumps 19.7% For KPTI
2017-01-03,Karyopharm To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016-12-15,Karyopharm And Collaborators Awarded Grant For ALS Research
2016-12-05,Karyopharm Presents Updated Phase 1b STOMP Data At The American Society Of Hematology 2016 Annual Meeting
2016-12-04,Karyopharm Presents Updated Phase 2b STORM Data At The American Society Of Hematology 2016 Annual Meeting
2016-12-04,Karyopharm Presents Updated Phase 2 SAIL Relapsed/Refractory AML Clinical Data At The American Society Of Hematology 2016 Annual Meeting
2016-11-30,Karyopharm And The Multiple Myeloma Research Foundation Announce Panel Discussion Featuring Leading Multiple Myeloma Thought Leaders
2016-11-10,Karyopharm To Present At The Jefferies 2016 London Healthcare Conference
2016-11-07,Karyopharm Reports Third Quarter 2016 Financial Results And Highlights Recent Progress
2016-11-03,Karyopharm To Present Updated Phase 2b STORM And Phase 1b STOMP Clinical Data At The American Society Of Hematology 2016 Annual Meeting
2016-11-02,Karyopharm To Ring The Nasdaq Stock Market Closing Bell
2016-10-31,Karyopharm To Report Third Quarter 2016 Financial Results On November 7, 2016
2016-10-28,Karyopharm Therapeutics is Now Oversold (KPTI)
2016-10-20,Commit To Purchase Karyopharm Therapeutics At $7.50, Earn 32.4% Annualized Using Options
2016-10-11,Karyopharm To Present At The 15th Annual BIO Investor Forum
2016-10-05,Karyopharm To Present Updated SIGN Phase 2 Clinical Data At European Society Of Medical Oncology 2016 Annual Meeting
2016-09-29,Karyopharm Publishes Preclinical Data In Nature Demonstrating Selinexor's Potential In KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
2016-09-28,Karyopharm Publishes Preclinical And Phase 1 Clinical Data For Selinexor In Ovarian Cancer In Clinical Cancer Research Publication
2016-09-12,Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP As Senior Vice President, Clinical Development
2016-09-06,Karyopharm Sees Quicker U.S. Approval Path for Multiple Myeloma Drug
2016-09-06,Karyopharm Reports Positive Top-Line Phase 2b STORM Results And Reviews The Planned Development Path For Selinexor In Multiple Myeloma
2016-08-30,Markets Very Sluggish as August Nears an End
2016-08-30,Karyopharm To Host Conference Call With Update On Multiple Myeloma Plans
2016-08-22,Noteworthy Monday Option Activity: KPTI, SHLD, MXWL
2016-08-19,These 7 Stocks Under $10 Could Make You a Lot of Money
2016-08-04,Karyopharm Reports Second Quarter 2016 Financial Results And Highlights Recent Progress
2016-08-03,Karyopharm To Present At Upcoming Investor Conferences
2016-07-28,Karyopharm To Report Second Quarter 2016 Financial Results On August 4, 2016
2016-07-27,Karyopharm To Present Updated Phase 2 Clinical Data From SIGN Study At European Society Of Medical Oncology 2016 Annual Meeting
2016-07-27,Karyopharm Announces Phase 1b Selinexor Sarcoma Data Published In Journal Of Clinical Oncology
2016-07-19,Commit To Purchase Karyopharm Therapeutics At $5, Earn 20.6% Annualized Using Options
2016-07-06,Karyopharm To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-06-22,Karyopharm Initiates Phase 1 Clinical Trial With KPT-9274
2016-06-16,Oversold Conditions For Karyopharm Therapeutics (KPTI)
2016-06-16,Karyopharm Outlines Key Selinexor Clinical Development Achievements
2016-06-15,Karyopharm To Present At The 2016 JMP Securities Life Science Conference
2016-06-10,Karyopharm Presents Preliminary STOMP Phase 1b Clinical Data At 2016 European Hematology Association Annual Meeting
2016-06-07,Insider Trading Alert - TRUP, KPTI And FCBC Traded By Insiders
2016-06-01,Karyopharm To Present At The Jefferies 2016 Healthcare Conference
2016-05-31,Insider Trading Alert - KPTI, CPIX And LB Traded By Insiders
2016-05-24,Insider Trading Alert - W, KPTI And GVP Traded By Insiders
2016-05-19,Karyopharm To Present Preliminary STOMP Phase 1B Clinical Data At 2016 European Hematology Association Annual Meeting
2016-05-18,Karyopharm To Present Selinexor Clinical Data At The American Society Of Clinical Oncology Annual Meeting
2016-05-09,Karyopharm Reports First Quarter 2016 Financial Results And Highlights Recent Progress
2016-05-02,Karyopharm To Report First Quarter 2016 Financial Results On May 9, 2016
2016-04-20,Karyopharm Presents Data Demonstrating The Potential Of Nuclear Export Protein Exportin 1 (XPO1) Inhibition In The Treatment Of Traumatic Brain Injury
2016-04-06,Karyopharm Taps TransPerfect As ETMF And Functional TMF Provider
2016-04-05,Karyopharm To Present At The 15th Annual Needham Healthcare Conference
2016-03-31,Karyopharm Receives NIAID Grant To Advance Development Of KPT-350 For The Treatment Of Lupus
2016-03-22,Karyopharm Therapeutics (KPTI) Strong On High Relative Volume Today
2016-03-16,Karyopharm To Present Data On Oncology Pipeline At The 2016 American Association For Cancer Research Annual Meeting
2016-03-14,Karyopharm Reports Fourth Quarter And Full Year 2015 Financial Results And Highlights Recent Progress
2016-03-07,Karyopharm To Report Fourth Quarter And Full Year 2015 Financial Results On March 14, 2016
2016-03-04,Karyopharm's Selinexor First-in-Human Phase 1 Clinical Trial Data Published In Journal Of Clinical Oncology
2016-03-02,7 Stocks Under $10 Making Big Breakout Moves
2016-02-03,Karyopharm To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-01-21,5 Stocks Under $10 Set to Soar
2016-01-19,Karyopharm Initiates Second Generation SINE™ Compound Clinical Trial In Multiple Myeloma
2016-01-14,Karyopharm Initiates Clinical Trial Of Oral Selinexor In Advanced Liposarcoma
2016-01-06,Karyopharm Therapeutics is Now Oversold (KPTI)
2016-01-06,Karyopharm Therapeutics (KPTI) Highlighted As Weak On High Volume
2016-01-04,Karyopharm To Present At The 34th Annual J.P. Morgan Healthcare Conference
2015-12-07,Karyopharm Therapeutics Presents Positive Clinical Data On The Activity Of Selinexor In Combination With Other Anticancer Agents Across Multiple Hematologic Malignancies At The 2015 American Society Of Hematology (ASH) Annual Meeting
2015-11-30,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Hematologic Malignancies
2015-11-13,Karyopharm Therapeutics Stock Sees Short Interest Drop 13.5%
2015-11-09,Karyopharm Reports Third Quarter 2015 Financial Results And Highlights Recent Progress
2015-11-05,Karyopharm To Present Data On Oncology Pipeline At American Society Of Hematology 2015 Annual Meeting
2015-11-02,Karyopharm To Report Third Quarter 2015 Financial Results On November 9, 2015
2015-10-30,5 Stocks Ready to Break Out Higher
2015-10-19,Karyopharm Initiates STOMP Clinical Trial Of Oral Selinexor In Multiple Myeloma
2015-10-13,Short Interest Falls 11% For KPTI
2015-09-30,10 Worst NASDAQ Biotech Stocks in the Third Quarter
2015-09-29,Karyopharm Therapeutics is Now Oversold (KPTI)
2015-09-03,Karyopharm Advancing Neuroprotective SINE(TM) Compounds In Amyotrophic Lateral Sclerosis (ALS)
2015-08-28,5 Breakout Stocks to Trade for Big Gains
2015-08-25,Strong On High Relative Volume: Karyopharm Therapeutics (KPTI)
2015-08-18,Karyopharm Therapeutics is Now Oversold (KPTI)
2015-08-18,Perilous Reversal Watch: Karyopharm Therapeutics (KPTI)
2015-08-17,Karyopharm Therapeutics (KPTI) Showing Signs Of A Dead Cat Bounce Today
2015-08-14,Weak On High Volume: Karyopharm Therapeutics (KPTI)
2015-08-11,Karyopharm Therapeutics (KPTI) Is Strong On High Volume Today
2015-08-10,Karyopharm Reports Second Quarter 2015 Financial Results And Highlights Recent Progress
2015-08-06,Commit To Purchase Karyopharm Therapeutics At $20, Earn 31% Annualized Using Options
2015-08-04,Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China
2015-08-03,Karyopharm To Report Second Quarter 2015 Financial Results On August 10, 2015
2015-07-24,Oversold Conditions For Karyopharm Therapeutics (KPTI)
2015-07-07,KPTI: Insiders Vs. Shorts
2015-06-26,Short Interest Increases 11.6% For KPTI
2015-06-22,Karyopharm Presents Hematologic Cancer Data On Lead Drug Candidate Selinexor At International Conference On Malignant Lymphoma
2015-06-15,Karyopharm Presents Hematologic Cancer Data On Lead Drug Candidate Selinexor At European Hematology Association Annual Meeting
2015-06-05,5 Biotech Stocks Poised for Breakouts
2015-06-04,'Mad Money' Lightning Round: Buy, Buy, Buy Juno Therapeutics
2015-06-03,Jim Cramer's 'Mad Money' Recap: Individual Stocks Beat Baskets Any Day
2015-06-01,Karyopharm Presents Clinical Data For Selinexor (KPT-330) In Patients With Recurrent Glioblastoma And Advanced Sarcomas At 2015 ASCO Annual Meeting
2015-05-30,Karyopharm Presents Clinical Data For Selinexor (KPT-330) In Patients With Heavily Pretreated Gynecological Cancers And Asian Patients With Advanced Malignancies At 2015 ASCO Annual Meeting
2015-05-29,Fly Watch: Several Names That May Move Following ASCO Meeting
2015-05-28,Karyopharm Initiates STORM Clinical Trial Of Oral Selinexor (KPT-330) In Multiple Myeloma
2015-05-27,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Solid Tumors
2015-05-21,Karyopharm To Present Hematologic Cancer Data On Lead Drug Candidate Selinexor At European Hematology Association Annual Meeting
2015-05-14,Karyopharm Therapeutics (KPTI) Stock: Weak On High Volume Today
2015-05-13,Karyopharm To Present Solid Tumor Data On Lead Drug Candidate Selinexor At 2015 American Society Of Clinical Oncology Annual Meeting
2015-05-13,Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts
2015-05-11,Karyopharm Reports First Quarter 2015 Financial Results And Highlights Recent Progress
2015-05-07,Karyopharm To Present At Bank Of America Merrill Lynch 2015 Healthcare Conference
2015-05-06,Commit To Purchase Karyopharm Therapeutics At $20, Earn 12.9% Annualized Using Options
2015-05-05,Karyopharm To Report First Quarter 2015 Financial Results On May 11, 2015
2015-04-17,Karyopharm To Present Late-Breaking Data At American Association For Cancer Research Annual Meeting
2015-04-14,Ratings Changes Today
2015-04-13,Karyopharm Granted U.S. Composition-of-Matter Patent For Selinexor (KPT-330)
2015-04-07,KPTI: Insiders Vs. Shorts
2015-04-02,'Mad Money' Lightning Round: Kinder Morgan, HCA Are Winners
2015-04-01,Jim Cramer's 'Mad Money' Recap: Get Ready for a Rough Ride
2015-04-01,Karyopharm Appoints Mikael Dolsten, MD, PhD To Its Board Of Directors
2015-03-18,Karyopharm To Present Data On Its Novel Oral PAK4 Allosteric Modulator (PAM) At The American Association For Cancer Research Annual Meeting
2015-03-18,Karyopharm To Present Data On Oncology Pipeline At American Association For Cancer Research Annual Meeting
2015-03-16,Karyopharm Reports Fourth Quarter And Full Year 2014 Financial Results And Highlights Recent Progress
2015-03-09,Karyopharm To Report Fourth Quarter And Full Year 2014 Financial Results On March 16, 2015
2015-02-23,Nature Neuroscience Publishes Data Demonstrating Potential Therapeutic Benefits Of Karyopharm's SINE(TM) Compounds In The Treatment Of Multiple Sclerosis
2015-02-05,Karyopharm To Present At Leerink Partners Global Healthcare Conference
2015-01-26,Commit To Purchase Karyopharm Therapeutics At $22.50, Earn 19.6% Annualized Using Options
2015-01-16,Karyopharm Therapeutics Is Now Oversold (KPTI)
2015-01-08,Karyopharm Announces Orphan Designation Granted By FDA For Selinexor (KPT-330) In Multiple Myeloma
2015-01-07,Karyopharm To Present At J.P. Morgan 33rd Annual Healthcare Conference
2015-01-06,Karyopharm Therapeutics Announces Pricing Of Public Offering Of Common Stock
2015-01-05,Karyopharm Therapeutics Announces Proposed Public Offering Of Common Stock
2014-12-15,Karyopharm Announces Addition To The NASDAQ Biotechnology Index
2014-12-11,Karyopharm Initiates Third Registration-Directed Clinical Trial Of Oral Selinexor (KPT-330)
2014-12-08,Jim Cramer's 'Mad Money' Recap: Why You Should Buy Disney, Starbucks, Nike Now
2014-12-08,Karyopharm Presents Positive Clinical Data For Selinexor (KPT-330) In NHL Patients At ASH 2014 Annual Meeting
2014-12-08,Karyopharm Presents Positive Combination Data For Selinexor (KPT-330) In Multiple Myeloma Patients At ASH 2014 Annual Meeting
2014-12-04,Karyopharm To Present At Oppenheimer 25th Annual Healthcare Conference
2014-12-01,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Oncology
2014-12-01,Karyopharm Announces Additional Orphan Designations Granted For Selinexor (KPT-330) By European Commission
2014-11-24,Karyopharm Presents Data On Oncology Pipeline At EORTC-NCI-AACR Annual Meeting
2014-11-10,Karyopharm Reports Third Quarter 2014 Financial Results And Highlights Recent Progress
2014-11-10,Karyopharm Initiates Registration-Directed Clinical Study Of Selinexor (KPT-330) In Patients With Richter's Transformation
2014-11-06,Karyopharm Announces Data Presentations At American Society Of Hematology Annual Meeting
2014-11-05,Karyopharm To Present At Credit Suisse 2014 Healthcare Conference
2014-11-04,Karyopharm Appoints J. Scott Garland To Its Board Of Directors
2014-10-30,Karyopharm To Report Third Quarter 2014 Financial Results On November 10, 2014
2014-10-27,Karyopharm Expands Global Presence With European Subsidiary
2014-09-29,Karyopharm Announces Clinical Data For Selinexor (KPT-330) In Advanced Solid Tumors
2014-09-29,3 Unusual-Volume Biotech Stocks in Breakout Territory
2014-09-25,Karyopharm To Host Conference Call To Discuss Selinexor (KPT-330) Data Presented At ESMO 2014
2014-09-09,Karyopharm Announces Three Clinical Data Presentations At ESMO 2014
2014-08-08,Karyopharm Appoints Justin Renz Executive Vice President And Chief Financial Officer
2014-08-07,Karyopharm To Present At The Wedbush 2014 Life Sciences Management Access Conference
2014-08-07,Karyopharm Therapeutics Reports Second Quarter Financial Results For 2014
2014-08-01,Karyopharm To Host Second Quarter 2014 Earnings Call On August 7, 2014
2014-06-17,A Beaten-Down Biotech Stock Poised for an Epic Short Squeeze
2014-06-03,3 Big-Volume Stocks in Breakout Territory
2014-05-30,ASCO '14: What's on Tap for Saturday
2014-05-28,5 Stocks Insiders Love Right Now
2017-03-16,Karyopharm Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Selinexor Clinical Update
2017-03-10,Karyopharm Announces Partial Clinical Hold To Pause Enrollment In Selinexor Trials
2017-03-09,Karyopharm To Report Fourth Quarter And Year End 2016 Financial Results On March 16, 2017
2017-03-03,Biotech Premarket Movers: Karyopharm, Lexicon, Prothena
2017-03-02,Karyopharm Announces Results From Interim Analysis Of Phase 2 SOPRA Study Evaluating Selinexor In Relapsed/Refractory Acute Myeloid Leukemia
2017-03-01,Karyopharm Announces The Presentation Of New Data At The 2017 American Association For Cancer Research Annual Meeting
2017-01-31,Karyopharm To Participate In Upcoming Investor Conferences
2017-01-19,Commit To Buy Karyopharm Therapeutics At $7.50, Earn 19.6% Annualized Using Options
2017-01-12,Short Interest Jumps 19.7% For KPTI
2017-01-03,Karyopharm To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016-12-15,Karyopharm And Collaborators Awarded Grant For ALS Research
2016-12-05,Karyopharm Presents Updated Phase 1b STOMP Data At The American Society Of Hematology 2016 Annual Meeting
2016-12-04,Karyopharm Presents Updated Phase 2b STORM Data At The American Society Of Hematology 2016 Annual Meeting
2016-12-04,Karyopharm Presents Updated Phase 2 SAIL Relapsed/Refractory AML Clinical Data At The American Society Of Hematology 2016 Annual Meeting
2016-11-30,Karyopharm And The Multiple Myeloma Research Foundation Announce Panel Discussion Featuring Leading Multiple Myeloma Thought Leaders
2016-11-10,Karyopharm To Present At The Jefferies 2016 London Healthcare Conference
2016-11-07,Karyopharm Reports Third Quarter 2016 Financial Results And Highlights Recent Progress
2016-11-03,Karyopharm To Present Updated Phase 2b STORM And Phase 1b STOMP Clinical Data At The American Society Of Hematology 2016 Annual Meeting
2016-11-02,Karyopharm To Ring The Nasdaq Stock Market Closing Bell
2016-10-31,Karyopharm To Report Third Quarter 2016 Financial Results On November 7, 2016
2016-10-28,Karyopharm Therapeutics is Now Oversold (KPTI)
2016-10-20,Commit To Purchase Karyopharm Therapeutics At $7.50, Earn 32.4% Annualized Using Options
2016-10-11,Karyopharm To Present At The 15th Annual BIO Investor Forum
2016-10-05,Karyopharm To Present Updated SIGN Phase 2 Clinical Data At European Society Of Medical Oncology 2016 Annual Meeting
2016-09-29,Karyopharm Publishes Preclinical Data In Nature Demonstrating Selinexor's Potential In KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)
2016-09-28,Karyopharm Publishes Preclinical And Phase 1 Clinical Data For Selinexor In Ovarian Cancer In Clinical Cancer Research Publication
2016-09-12,Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP As Senior Vice President, Clinical Development
2016-09-06,Karyopharm Sees Quicker U.S. Approval Path for Multiple Myeloma Drug
2016-09-06,Karyopharm Reports Positive Top-Line Phase 2b STORM Results And Reviews The Planned Development Path For Selinexor In Multiple Myeloma
2016-08-30,Markets Very Sluggish as August Nears an End
2016-08-30,Karyopharm To Host Conference Call With Update On Multiple Myeloma Plans
2016-08-22,Noteworthy Monday Option Activity: KPTI, SHLD, MXWL
2016-08-19,These 7 Stocks Under $10 Could Make You a Lot of Money
2016-08-04,Karyopharm Reports Second Quarter 2016 Financial Results And Highlights Recent Progress
2016-08-03,Karyopharm To Present At Upcoming Investor Conferences
2016-07-28,Karyopharm To Report Second Quarter 2016 Financial Results On August 4, 2016
2016-07-27,Karyopharm To Present Updated Phase 2 Clinical Data From SIGN Study At European Society Of Medical Oncology 2016 Annual Meeting
2016-07-27,Karyopharm Announces Phase 1b Selinexor Sarcoma Data Published In Journal Of Clinical Oncology
2016-07-19,Commit To Purchase Karyopharm Therapeutics At $5, Earn 20.6% Annualized Using Options
2016-07-06,Karyopharm To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-06-22,Karyopharm Initiates Phase 1 Clinical Trial With KPT-9274
2016-06-16,Oversold Conditions For Karyopharm Therapeutics (KPTI)
2016-06-16,Karyopharm Outlines Key Selinexor Clinical Development Achievements
2016-06-15,Karyopharm To Present At The 2016 JMP Securities Life Science Conference
2016-06-10,Karyopharm Presents Preliminary STOMP Phase 1b Clinical Data At 2016 European Hematology Association Annual Meeting
2016-06-07,Insider Trading Alert - TRUP, KPTI And FCBC Traded By Insiders
2016-06-01,Karyopharm To Present At The Jefferies 2016 Healthcare Conference
2016-05-31,Insider Trading Alert - KPTI, CPIX And LB Traded By Insiders
2016-05-24,Insider Trading Alert - W, KPTI And GVP Traded By Insiders
2016-05-19,Karyopharm To Present Preliminary STOMP Phase 1B Clinical Data At 2016 European Hematology Association Annual Meeting
2016-05-18,Karyopharm To Present Selinexor Clinical Data At The American Society Of Clinical Oncology Annual Meeting
2016-05-09,Karyopharm Reports First Quarter 2016 Financial Results And Highlights Recent Progress
2016-05-02,Karyopharm To Report First Quarter 2016 Financial Results On May 9, 2016
2016-04-20,Karyopharm Presents Data Demonstrating The Potential Of Nuclear Export Protein Exportin 1 (XPO1) Inhibition In The Treatment Of Traumatic Brain Injury
2016-04-06,Karyopharm Taps TransPerfect As ETMF And Functional TMF Provider
2016-04-05,Karyopharm To Present At The 15th Annual Needham Healthcare Conference
2016-03-31,Karyopharm Receives NIAID Grant To Advance Development Of KPT-350 For The Treatment Of Lupus
2016-03-22,Karyopharm Therapeutics (KPTI) Strong On High Relative Volume Today
2016-03-16,Karyopharm To Present Data On Oncology Pipeline At The 2016 American Association For Cancer Research Annual Meeting
2016-03-14,Karyopharm Reports Fourth Quarter And Full Year 2015 Financial Results And Highlights Recent Progress
2016-03-07,Karyopharm To Report Fourth Quarter And Full Year 2015 Financial Results On March 14, 2016
2016-03-04,Karyopharm's Selinexor First-in-Human Phase 1 Clinical Trial Data Published In Journal Of Clinical Oncology
2016-03-02,7 Stocks Under $10 Making Big Breakout Moves
2016-02-03,Karyopharm To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-01-21,5 Stocks Under $10 Set to Soar
2016-01-19,Karyopharm Initiates Second Generation SINE™ Compound Clinical Trial In Multiple Myeloma
2016-01-14,Karyopharm Initiates Clinical Trial Of Oral Selinexor In Advanced Liposarcoma
2016-01-06,Karyopharm Therapeutics is Now Oversold (KPTI)
2016-01-06,Karyopharm Therapeutics (KPTI) Highlighted As Weak On High Volume
2016-01-04,Karyopharm To Present At The 34th Annual J.P. Morgan Healthcare Conference
2015-12-07,Karyopharm Therapeutics Presents Positive Clinical Data On The Activity Of Selinexor In Combination With Other Anticancer Agents Across Multiple Hematologic Malignancies At The 2015 American Society Of Hematology (ASH) Annual Meeting
2015-11-30,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Hematologic Malignancies
2015-11-13,Karyopharm Therapeutics Stock Sees Short Interest Drop 13.5%
2015-11-09,Karyopharm Reports Third Quarter 2015 Financial Results And Highlights Recent Progress
2015-11-05,Karyopharm To Present Data On Oncology Pipeline At American Society Of Hematology 2015 Annual Meeting
2015-11-02,Karyopharm To Report Third Quarter 2015 Financial Results On November 9, 2015
2015-10-30,5 Stocks Ready to Break Out Higher
2015-10-19,Karyopharm Initiates STOMP Clinical Trial Of Oral Selinexor In Multiple Myeloma
2015-10-13,Short Interest Falls 11% For KPTI
2015-09-30,10 Worst NASDAQ Biotech Stocks in the Third Quarter
2015-09-29,Karyopharm Therapeutics is Now Oversold (KPTI)
2015-09-03,Karyopharm Advancing Neuroprotective SINE(TM) Compounds In Amyotrophic Lateral Sclerosis (ALS)
2015-08-28,5 Breakout Stocks to Trade for Big Gains
2015-08-25,Strong On High Relative Volume: Karyopharm Therapeutics (KPTI)
2015-08-18,Karyopharm Therapeutics is Now Oversold (KPTI)
2015-08-18,Perilous Reversal Watch: Karyopharm Therapeutics (KPTI)
2015-08-17,Karyopharm Therapeutics (KPTI) Showing Signs Of A Dead Cat Bounce Today
2015-08-14,Weak On High Volume: Karyopharm Therapeutics (KPTI)
2015-08-11,Karyopharm Therapeutics (KPTI) Is Strong On High Volume Today
2015-08-10,Karyopharm Reports Second Quarter 2015 Financial Results And Highlights Recent Progress
2015-08-06,Commit To Purchase Karyopharm Therapeutics At $20, Earn 31% Annualized Using Options
2015-08-04,Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China
2015-08-03,Karyopharm To Report Second Quarter 2015 Financial Results On August 10, 2015
2015-07-24,Oversold Conditions For Karyopharm Therapeutics (KPTI)
2015-07-07,KPTI: Insiders Vs. Shorts
2015-06-26,Short Interest Increases 11.6% For KPTI
2015-06-22,Karyopharm Presents Hematologic Cancer Data On Lead Drug Candidate Selinexor At International Conference On Malignant Lymphoma
2015-06-15,Karyopharm Presents Hematologic Cancer Data On Lead Drug Candidate Selinexor At European Hematology Association Annual Meeting
2015-06-05,5 Biotech Stocks Poised for Breakouts
2015-06-04,'Mad Money' Lightning Round: Buy, Buy, Buy Juno Therapeutics
2015-06-03,Jim Cramer's 'Mad Money' Recap: Individual Stocks Beat Baskets Any Day
2015-06-01,Karyopharm Presents Clinical Data For Selinexor (KPT-330) In Patients With Recurrent Glioblastoma And Advanced Sarcomas At 2015 ASCO Annual Meeting
2015-05-30,Karyopharm Presents Clinical Data For Selinexor (KPT-330) In Patients With Heavily Pretreated Gynecological Cancers And Asian Patients With Advanced Malignancies At 2015 ASCO Annual Meeting
2015-05-29,Fly Watch: Several Names That May Move Following ASCO Meeting
2015-05-28,Karyopharm Initiates STORM Clinical Trial Of Oral Selinexor (KPT-330) In Multiple Myeloma
2015-05-27,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Solid Tumors
2015-05-21,Karyopharm To Present Hematologic Cancer Data On Lead Drug Candidate Selinexor At European Hematology Association Annual Meeting
2015-05-14,Karyopharm Therapeutics (KPTI) Stock: Weak On High Volume Today
2015-05-13,Karyopharm To Present Solid Tumor Data On Lead Drug Candidate Selinexor At 2015 American Society Of Clinical Oncology Annual Meeting
2015-05-13,Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts
2015-05-11,Karyopharm Reports First Quarter 2015 Financial Results And Highlights Recent Progress
2015-05-07,Karyopharm To Present At Bank Of America Merrill Lynch 2015 Healthcare Conference
2015-05-06,Commit To Purchase Karyopharm Therapeutics At $20, Earn 12.9% Annualized Using Options
2015-05-05,Karyopharm To Report First Quarter 2015 Financial Results On May 11, 2015
2015-04-17,Karyopharm To Present Late-Breaking Data At American Association For Cancer Research Annual Meeting
2015-04-14,Ratings Changes Today
2015-04-13,Karyopharm Granted U.S. Composition-of-Matter Patent For Selinexor (KPT-330)
2015-04-07,KPTI: Insiders Vs. Shorts
2015-04-02,'Mad Money' Lightning Round: Kinder Morgan, HCA Are Winners
2015-04-01,Jim Cramer's 'Mad Money' Recap: Get Ready for a Rough Ride
2015-04-01,Karyopharm Appoints Mikael Dolsten, MD, PhD To Its Board Of Directors
2015-03-18,Karyopharm To Present Data On Its Novel Oral PAK4 Allosteric Modulator (PAM) At The American Association For Cancer Research Annual Meeting
2015-03-18,Karyopharm To Present Data On Oncology Pipeline At American Association For Cancer Research Annual Meeting
2015-03-16,Karyopharm Reports Fourth Quarter And Full Year 2014 Financial Results And Highlights Recent Progress
2015-03-09,Karyopharm To Report Fourth Quarter And Full Year 2014 Financial Results On March 16, 2015
2015-02-23,Nature Neuroscience Publishes Data Demonstrating Potential Therapeutic Benefits Of Karyopharm's SINE(TM) Compounds In The Treatment Of Multiple Sclerosis
2015-02-05,Karyopharm To Present At Leerink Partners Global Healthcare Conference
2015-01-26,Commit To Purchase Karyopharm Therapeutics At $22.50, Earn 19.6% Annualized Using Options
2015-01-16,Karyopharm Therapeutics Is Now Oversold (KPTI)
2015-01-08,Karyopharm Announces Orphan Designation Granted By FDA For Selinexor (KPT-330) In Multiple Myeloma
2015-01-07,Karyopharm To Present At J.P. Morgan 33rd Annual Healthcare Conference
2015-01-06,Karyopharm Therapeutics Announces Pricing Of Public Offering Of Common Stock
2015-01-05,Karyopharm Therapeutics Announces Proposed Public Offering Of Common Stock
2014-12-15,Karyopharm Announces Addition To The NASDAQ Biotechnology Index
2014-12-11,Karyopharm Initiates Third Registration-Directed Clinical Trial Of Oral Selinexor (KPT-330)
2014-12-08,Jim Cramer's 'Mad Money' Recap: Why You Should Buy Disney, Starbucks, Nike Now
2014-12-08,Karyopharm Presents Positive Clinical Data For Selinexor (KPT-330) In NHL Patients At ASH 2014 Annual Meeting
2014-12-08,Karyopharm Presents Positive Combination Data For Selinexor (KPT-330) In Multiple Myeloma Patients At ASH 2014 Annual Meeting
2014-12-04,Karyopharm To Present At Oppenheimer 25th Annual Healthcare Conference
2014-12-01,Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Oncology
2014-12-01,Karyopharm Announces Additional Orphan Designations Granted For Selinexor (KPT-330) By European Commission
2014-11-24,Karyopharm Presents Data On Oncology Pipeline At EORTC-NCI-AACR Annual Meeting
2014-11-10,Karyopharm Reports Third Quarter 2014 Financial Results And Highlights Recent Progress
2014-11-10,Karyopharm Initiates Registration-Directed Clinical Study Of Selinexor (KPT-330) In Patients With Richter's Transformation
2014-11-06,Karyopharm Announces Data Presentations At American Society Of Hematology Annual Meeting
2014-11-05,Karyopharm To Present At Credit Suisse 2014 Healthcare Conference
2014-11-04,Karyopharm Appoints J. Scott Garland To Its Board Of Directors
2014-10-30,Karyopharm To Report Third Quarter 2014 Financial Results On November 10, 2014
2014-10-27,Karyopharm Expands Global Presence With European Subsidiary
2014-09-29,Karyopharm Announces Clinical Data For Selinexor (KPT-330) In Advanced Solid Tumors
2014-09-29,3 Unusual-Volume Biotech Stocks in Breakout Territory
2014-09-25,Karyopharm To Host Conference Call To Discuss Selinexor (KPT-330) Data Presented At ESMO 2014
2014-09-09,Karyopharm Announces Three Clinical Data Presentations At ESMO 2014
2014-08-08,Karyopharm Appoints Justin Renz Executive Vice President And Chief Financial Officer
2014-08-07,Karyopharm To Present At The Wedbush 2014 Life Sciences Management Access Conference
2014-08-07,Karyopharm Therapeutics Reports Second Quarter Financial Results For 2014
2014-08-01,Karyopharm To Host Second Quarter 2014 Earnings Call On August 7, 2014
2014-06-17,A Beaten-Down Biotech Stock Poised for an Epic Short Squeeze
2014-06-03,3 Big-Volume Stocks in Breakout Territory
2014-05-30,ASCO '14: What's on Tap for Saturday
2014-05-28,5 Stocks Insiders Love Right Now
